Intelligent Bio Solutions (INBS) Consolidated Net Income (2019 - 2025)

Intelligent Bio Solutions has reported Consolidated Net Income for 7 years, with the latest figure at -$2.6 million in Q1 2025.

• For the quarter ending Q1 2025, Consolidated Net Income rose 14.58% year-over-year to -$2.6 million; the trailing twelve-month figure through Jun 2025 stood at -$7.5 million (up 27.74% YoY), and the FY2024 full-year result was -$10.3 million, up 18.29% from the prior year.
• Consolidated Net Income for Q1 2025 stood at -$2.6 million, down from -$2.3 million in the prior quarter.
• The five-year high for Consolidated Net Income was -$850230.0 in Q2 2021, with the low at -$6.4 million in Q1 2023.
• Average Consolidated Net Income over 5 years is -$2.5 million, with a median of -$2.6 million recorded in 2025.
• Year-over-year, Consolidated Net Income sank 2728.5% in 2021 and jumped 57.23% in 2022.
• Tracing INBS's Consolidated Net Income over 5 years: stood at -$3.5 million in 2021, then surged by 38.52% to -$2.1 million in 2022, then advanced by 5.13% to -$2.0 million in 2023, then slipped by 11.67% to -$2.3 million in 2024, then retreated by 13.05% to -$2.6 million in 2025.
• The last three Consolidated Net Income figures came in at -$2.6 million (Q1 2025), -$2.3 million (Q4 2024), and -$2.7 million (Q3 2024), per Business Quant data.

Peer Comparison